Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Cyclophosphamide for Severe Autoimmune Enteropathy
NCT00258180Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2005
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in autoimmune enteropathy (AIE), sponsored by Johns Hopkins University. Started Aug 2005; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
autoimmune enteropathy (AIE)
Beyond the preview
Go deeper on NCT00258180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258180.